Search results
Found 22819 matches for
A new statement has been released from Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY Trial. RECOVERY was established in March as a randomised clinical trial to test a range of potential drugs for COVID-19, including hydroxycholoroquine. The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. The chief investigators have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19.
Evelyne Kestelyn
Evelyne Kestelyn - Head of the Clinical Trials Unit
Bridget Wills
Bridget Wills - Professor of Tropical Medicine
Louise Thwaites
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Professor of Experimental Critical Care
Paul Newton
Paul Newton - Professor of Tropical Medicine
Wirichada Pan-ngum
Wirichada Pan-ngum - Associate Professor
Direk Limmathurotsakul
Direk Limmathurotsakul - Professor of Infectious Disease Epidemiology
Richard Hoglund
Richard Hoglund - Head of Pharmacometrics
Mehul Dhorda
Mehul Dhorda - DeTACT-Africa Coordinator / Head of Specimen Management Laboratory
Raph Hamers
MD PhD Raph Hamers - Associate Professor in Infectious Diseases
Stuart Blacksell
BAppSc MPH PhD RBP(ABSA) FASM FFSc(RCPA) TechIOSH Stuart Blacksell - Professor of Tropical Microbiology
Nicholas White
FRS Nicholas White - Professor of Tropical Medicine